Prognos, a New York City-based artificial intelligence company, has wrapped up a $20.5 million Series C financing round from investors such as Cigna, Merck Global Health Innovation Fund, Hermed, Hikma Ventures, GIS Strategic Ventures, Maywic and Safeguard Scientifics.
As part of the relaunch, New York-based Prognos is making an aggressive push into the payer market to augment its predictive analytics work with life sciences and diagnostics clients.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
On Monday night, health entrepreneurs, investors and industry insiders celebrated a new class of “healthcare transformers” as well as the industry’s complete and official arrival in the digital world of SXSW. StartUp Health and Health 2.0 hosted a happy hour at The Hangar Bar in Austin and introduced two entrepreneurs who will be participating in […]
A healthcare IT company has acquired a disease management platform to expand into the mobile health sector. Medivo, which provides support services to patients and physician practices, acquired New Jersey-based WellApps for an undisclosed amount. WellApps’ GI Monitor helps users log and track their symptoms and provide that data to their physicians. It also helps […]
Safeguard Scientifics (NYSE:SFE) has led a $7 million series A round of investment for Medivo, a New York-based healthcare IT company that provides data analytics and lab testing services. Last month, Safeguard consolidated its life sciences and technology portfolios, and said it wants to grow healthcare IT to one-quarter of its investments, with investments informed […]